This topic contains 0 replies, has 1 voice, and was last updated by 
Pulmonary Fibrosis News Moderator 10 months ago.
-
Posts
-
Real-world U.K. data found poorer lung function at the start of Ofev treatment, plus older age, marked patients with IPF who stopped using it. Click here to read more.
What do you think about this study and its findings?
You must be logged in to reply to this topic.
